Atlas Trials

Effects of Ocrevus in Relapsing Multiple Sclerosis

Clinical trial NCT04387734 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04387734
Sponsor
Georgia State University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Relapsing Multiple Sclerosis
Start date
2021-02-05
Primary completion
2025-02-17
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.